Compare · NTIC vs ZBH
NTIC vs ZBH
Side-by-side comparison of Northern Technologies International Corporation (NTIC) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- NTIC operates in Industrials, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $17.63B, about 235.0x NTIC ($75.0M).
- NTIC has been more active in the news (14 items in the past 4 weeks vs 4 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 0 for NTIC).
- Company
- Northern Technologies International Corporation
- Zimmer Biomet Holdings Inc.
- Price
- $7.91-1.12%
- $92.39-2.34%
- Market cap
- $75.0M
- $17.63B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 14
- 4
- Recent ratings
- 0
- 25
Northern Technologies International Corporation
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest NTIC
- President and CEO Ramdas Gautam was granted 43,805 shares, increasing direct ownership by 58% to 118,932 units (SEC Form 4)
- New insider Ramdas Gautam claimed ownership of 75,127 shares (SEC Form 3)
- New insider Haglund Brian James claimed ownership of 1,589 shares (SEC Form 3)
- Northern Technologies International Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Northern Technologies International Corporation Announces New President and CEO and Other Key Leadership Appointments
- SEC Form 4 filed by President and CEO Lynch G Patrick
- SEC Form 4 filed by CFO and Corporate Secretary Wolsfeld Matthew C
- Director Nigon Richard was granted 7,426 shares, increasing direct ownership by 16% to 54,574 units (SEC Form 4)
- Director Lee Sunggyu was granted 6,188 shares, increasing direct ownership by 186% to 9,507 units (SEC Form 4)
- Director Kemp Sarah E. was granted 6,188 shares, increasing direct ownership by 38% to 22,458 units (SEC Form 4)
Latest ZBH
- Officer Phipps Chad F sold $295,050 worth of shares (3,000 units at $98.35), decreasing direct ownership by 4% to 65,231 units (SEC Form 4)
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure
- Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
- Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results